Honeywell will showcase an integrated, AI-enabled building automation and security ecosystem across seven immersive environments at ISC West 2026, highlighting how its ...
The investigators found that dd-cfDNA levels increased with histological evidence of graft inflammation, with the strongest associations observed in microvascular inflammation (MVI) and ...
UBS Global Consumer and Retail Conference March 11, 2026 1:00 PM EDTCompany ParticipantsHarmit Singh - Executive VP ...
Study affirms superiority of iMDx GraftAssure assay’s proprietary dd-cfDNA combination model score: Nashville, Tennessee Monday, March 16, 2026, 18:00 Hrs [IST] Insight Molecula ...
Q4 FY2025 earnings call recap: 9% sales growth, 5% comps, multi-price expansion, margin outlook and 2026 guidance—read key takeaways now.
Thank you so much, Jon, and thank you all for joining us today. First, we are continuing to prioritize customer growth and ...
Calix builds growth on BEAD-funded fiber, Gen3 shift and agentic AI, with strong backlog visibility but timing and margin noise still in focus.
Irvine-based Tarsus Pharmaceuticals posted blockbuster Q4 and full year revenues driven by surging demand for its eyedrop ...
New data supports GraftAssure commercialization effortsMulti-center study featured 249 biopsy-matched patientsProprietary "Combination Model" score outperformed percentage-only measures of dd-cfDNARei ...
HeartBeam (Nasdaq:BEAT) announced today that it entered into a strategic collaboration with the Icahn School of Medicine at Mount Sinai.
As Asia’s population ages and healthcare demands rise, femtech is emerging as a mainstream growth opportunity Read more at The Business Times.
Kostman noted, "The 2025 trimming of our supply and demand sources to ensure higher quality will impact our year-over-year comparisons early on," with soft year-over-year performance expected through ...
Some results have been hidden because they may be inaccessible to you
Show inaccessible results